Estimated reading time: 1 minutes
Early diagnosis of hepatocellular carcinoma (HCC) — one of the most fatal malignancies — is crucial to improve patient survival. In a breakthrough study investigators report on the development of a serum fusion-gene machine-learning model. This important screening tool may increase the five-year survival rate of patients with HCC from 20% to 90% because of its improved accuracy in early diagnosis of HCC and monitoring the impact of treatment.
About The Author
Discover more from Life is Pro-Mazing!
Subscribe to get the latest posts sent to your email.